Tyers Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Tyers Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$110K	Hold	1,936	–	–	﹤0.01%	830
2019 Q2	$108K	Hold	1,936	–	–	﹤0.01%	838
2019 Q1	$98K	Hold	1,936	–	–	﹤0.01%	844
2018 Q4	$78K	Buy	1,936 +374	+24%	+$19.3K	﹤0.01%	837
2018 Q3	$108K	Buy	1,562 +132	+9%	+$10K	﹤0.01%	858
2018 Q2	$108K	Hold	1,430	–	–	﹤0.01%	824
2018 Q1	$75K	Buy	1,430 +242	+20%	+$14.1K	﹤0.01%	896
2017 Q4	$64K	Buy	1,188 +220	+23%	+$12.2K	﹤0.01%	922
2017 Q3	$58K	Buy	968 +286	+42%	+$17.3K	﹤0.01%	913
2017 Q2	$54K	Buy	682 +374	+121%	+$30.6K	﹤0.01%	909
2017 Q1	$26K	Buy	+308	New	+$22.9K	﹤0.01%	928

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Tyers Asset Management's EGRX Position: Q3 2019 in Review

Tyers Asset Management held its Eagle Pharmaceuticals, Inc. (EGRX) position steady in Q3 2019 at 1,936 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Tyers Asset Management first reported a position in EGRX in Q1 2017 and has held it in 11 quarters since. 183 funds tracked by Wall St. Rank hold EGRX as of Q3 2019.

Tyers Asset Management held 1,936 shares of Eagle Pharmaceuticals, Inc. worth $110K as of Q3 2019.
Tyers Asset Management left its Eagle Pharmaceuticals, Inc. share count unchanged in Q3 2019.
Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #830 holding.
Tyers Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2017 and has held it in 11 quarters since.
183 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.